U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 7 of 7 results

Status:
US Approved Rx (2024)
First approved in 2015

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ivabradine (CORLANOR®) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker that reduces the spontaneous pacemaker activity of the cardiac sinus node by selectively inhibiting the If-current, resulting in heart rate reduction at c...
Status:
US Approved Rx (2024)
First approved in 2015

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ivabradine (CORLANOR®) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker that reduces the spontaneous pacemaker activity of the cardiac sinus node by selectively inhibiting the If-current, resulting in heart rate reduction at c...
Status:
US Approved Rx (2024)
First approved in 2015

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ivabradine (CORLANOR®) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker that reduces the spontaneous pacemaker activity of the cardiac sinus node by selectively inhibiting the If-current, resulting in heart rate reduction at c...
Status:
US Approved Rx (2024)
First approved in 2015

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ivabradine (CORLANOR®) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker that reduces the spontaneous pacemaker activity of the cardiac sinus node by selectively inhibiting the If-current, resulting in heart rate reduction at c...
Status:
US Approved Rx (2024)
First approved in 2015

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ivabradine (CORLANOR®) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker that reduces the spontaneous pacemaker activity of the cardiac sinus node by selectively inhibiting the If-current, resulting in heart rate reduction at c...
Status:
US Approved Rx (2024)
First approved in 2015

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ivabradine (CORLANOR®) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker that reduces the spontaneous pacemaker activity of the cardiac sinus node by selectively inhibiting the If-current, resulting in heart rate reduction at c...
Status:
US Approved Rx (2024)
First approved in 2015

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ivabradine (CORLANOR®) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker that reduces the spontaneous pacemaker activity of the cardiac sinus node by selectively inhibiting the If-current, resulting in heart rate reduction at c...